Evidence map›Paper›PMID 26373802›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content.

Ali Pedram, Mahnaz Razandi, Bruce Blumberg, Ellis Robert Levin

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 78 citations in OpenAlex.

  1. Metabolic Messengers: testosterone.Nature metabolism · 2026
    Review
  2. ERα36 PromotesInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Endocrine therapy resistance: what we know and future directions.Exploration of targeted anti-tumor therapy · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Impact of estrogens in males and androgens in females.The Journal of clinical investigation · 2019
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ali Pedram*Division of Endocrinology, Veterans Affairs Medical Center, Long Beach, California, USA; Department of Developmental and Cell Biology, Department of Medicine, and Department of Biochemistry, University of California, Irvine, Irvine, California, USA.
Mahnaz Razandi*Division of Endocrinology, Veterans Affairs Medical Center, Long Beach, California, USA; Department of Developmental and Cell Biology, Department of Medicine, and Department of Biochemistry, University of California, Irvine, Irvine, California, USA.
Bruce Blumberg*Division of Endocrinology, Veterans Affairs Medical Center, Long Beach, California, USA; Department of Developmental and Cell Biology, Department of Medicine, and Department of Biochemistry, University of California, Irvine, Irvine, California, USA.
Ellis Robert Levin*Division of Endocrinology, Veterans Affairs Medical Center, Long Beach, California, USA; Department of Developmental and Cell Biology, Department of Medicine, and Department of Biochemistry, University of California, Irvine, Irvine, California, USA ellis.levin@va.gov.
Long Beach Medical Center · USIrvine University · USUniversity of California, Irvine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Joel E Milam · 1994 to 2026
$57.9M
Estrogen receptor and the cardiovascular systemI01BX002316 · VA · VETERANS HEALTH ADMINISTRATION · PI LEVIN, ELLIS R · 2014 to 2022
–
BLRD VA I01 BX002316NCI NIH HHS CA-10036NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

Estrogen and estrogen receptor (ER)-α suppress visceral fat development through actions in several organs via unclear mechanisms that we sought to identify. Using mice that express only nuclear ER-α [nuclear-only ER-α (NOER) mice] or plasma membrane ER-α [membrane-only ER-α (MOER) mice], we found that 10-wk-old mice that lacked either receptor pool showed extensive abdominal visceral fat deposition and weight gain compared with wild-type (WT) mice. Differentiation of cultured bone marrow stem cells (BMSCs) into the adipocyte lineage was suppressed by 17-β-estradiol (E2) in WT female mice but not in NOER or MOER mice. This finding correlated with E2 inhibition of prominent differentiation genes in WT BMSCs. In contrast, triglyceride content in differentiated BMSCs or 3T3-L1 cells was suppressed as a result of membrane ER-α signaling through several kinases to inhibit carbohydrate response element-binding protein-α and -β. We concluded that extranuclear and nuclear ER-α collaborate to suppress adipocyte development, but inhibition of lipid synthesis in mature cells does not involve nuclear ER-α.

Indexed as

AdipogenesisAnimalsCell MembraneCell NucleusCells, CulturedCyclic AMP Response Element-Binding ProteinEstradiolEstrogen Receptor alphaFemaleMesenchymal Stem CellsMiceTriglyceridesCyclic AMP Response Element-Binding ProteinEstradiolEstrogen Receptor alphaTriglyceridesadipocyte hypertrophyBMSCsChREBPkinase activationpreadipocytes

Identifiers

PMID26373802
PMCPMC4684544
OpenAlexW2227807199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.